EDGAR Filing Documents for 0001193125-13-420273

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-13-420273

Filing Date

2013-10-31

Accepted

2013-10-31 12:10:35

Documents

Period of Report

2013-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d621723d20f.htm	20-F	1944692
2	EX-8.1	d621723dex81.htm	EX-8.1	13008
3	EX-12.1	d621723dex121.htm	EX-12.1	9387
4	EX-12.2	d621723dex122.htm	EX-12.2	9398
5	EX-13.1	d621723dex131.htm	EX-13.1	4755
6	GRAPHIC	g621723tx_pg109.jpg	GRAPHIC	10808
7	GRAPHIC	g621723tx_pg110.jpg	GRAPHIC	5821
	Complete submission text file	0001193125-13-420273.txt		2005456

Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077

Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088

NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 131181587
SIC: 2834 Pharmaceutical Preparations